HiFiBiO Company
HiFiBiO provides proprietary single cell technologies for applications in drug and biomarker discovery and development.
Investors
Industry:
Early Drug Development
Headquarters:
Paris, Ile-de-France, France
Founded Date:
2013-01-01
Employees Number:
101-250
Funding Status:
Late Stage Venture
Investors Number:
21
Total Funding:
179500000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2021-06-14
Last Funding Type:
Series D
Register and Claim Ownership